Menu

News & Insights

  • Clear

Connecticut and Minnesota AGs Latest to Shine Light on Allegedly Deceptive Practices in the Solar Industry

Connecticut AG William Tong has sued multiple solar panel sales and installation companies over alleged consumer protection violations, while Minnesota AG Keith Ellison has settled investigations into several solar installers and advertisers over similar allegations.

Read More

Nebraska AG Settles Delta-8 Lawsuits Against Four Retailers

Nebraska AG Mike Hilgers has announced four additional settlements in a series of lawsuits filed against retailers for allegedly selling mislabeled and harmful products containing synthetic THC in violation of Nebraska’s consumer protection laws. The complaints against retailers Greenhouse Grandma LLC, A Botanical Dream, LLC, First Stop Vape Shop, and Zy Glam, LLC each alleged…

Read More

Arizona AG Alleges “Super Clean” Trucks Violate Emissions Standards

Arizona Attorney General Kris Mayes sued FCA US LLC (d/b/a Fiat Chrysler Automobiles) and Cummins, Inc. (Cummins) alleging that the engine and vehicle manufacturers violated Arizona consumer protection laws by installing illegal defeat devices to bypass vehicle emissions control equipment in diesel engines on certain RAM pickup trucks, leading to excess emissions. As alleged in…

Read More

FTC Announces New Efforts Targeting Unfair and Deceptive Franchisor Practices

The FTC announced that it has taken multiple actions to address growing concern about unfair and deceptive practices by franchisors. The FTC released a Policy Statement on Franchisors’ Use of Contract Provisions, Including Non-Disparagement, Goodwill, and Confidentiality Clauses, which warns franchisors that the use of contract provisions, such as non-disparagement clauses that prohibit franchisees’ communications with the…

Read More

Democratic AGs File Amicus Brief Supporting Drug Pricing Transparency Law

A group of 21 Democratic AGs filed an amicus brief with the U.S. Court of Appeals for the Ninth Circuit supporting Oregon in its defense of H.B. 4005, which requires pharmaceutical manufacturers to report certain information about specific new prescription drugs and historical information about pricing for existing drugs. The U.S. District Court for the District of Oregon had…

Read More